Moonshots For Unicorns
- Assets
- $328.6k
- Revenue
- $143.6k
- Investments
- $0.0
- Employees
- 0
- Location
- Berkeley, CA
- Founding
- Data as of
- 12/2023
- EIN
- 88-2730106
Organization Overview
Moonshots For Unicorns is located in Berkeley, CA. According to its NTEE Classification (U50) the organization is classified as: Biological & Life Sciences, under the broad grouping of Science & Technology and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Moonshots For Unicorns is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Moonshots For Unicorns generated $143.6k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 2 years, the organization has seen revenues fall by an average of (40.0%) each year. All expenses for the organization totaled $70.3k during the year ending 12/2023. As we would expect to see with falling revenues, expenses have declined by (30.2%) per year over the past 2 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
MOONSHOTS FOR UNICORNS RAISES FUNDS TO SPONSOR SCIENTIFIC AND MEDICAL RESEARCH AIMED AT CURING SINGLE GENE DISORDERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THESE GRANTS WERE MADE TO THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL TO SUPPORT RESEARCH AIMED AT CREATING AN EFFECTIVE GENE THERAPY TO CURE THE MONOGENIC DISORDER PGAP3-CDG. THE MONEY SUPPORTED CREATION OF A SECOND PATIENT CELL LINE, TESTING OF EXPERIMENTAL GENE THERAPY VECTORS ON PATIENT CELLS AND MICE, AND SMALL MOLECULE TESTING ON PATIENT CELLS.
THIS GRANT SUPPORTED DRUG REPURPOSING RESEARCH AIMED AT CURING THE MONOGENIC DISORDER PGAP3-CDG. MOONSHOTS FUNDED WORK BY PERLARA LLC AND UCSF TO CREATE PGAP3 KNOCKOUT YEAST AND SCREEN A LIBRARY OF 12,000 EXISTING COMPOUNDS ON THEM TO SEE IF THEIR GROWTH AND FUNCTION WERE IMPROVED. THIS LED TO THE DISCOVERY OF SEVERAL SAFE MEDICATIONS AND SUPPLEMENTS THAT CAN BE TAKEN BY CHILDREN WITH PGAP3-CDG THAT HELP SUPPORT THEIR NERVE CELLS AND IMPROVE THEIR DAILY FUNCTIONING. THIS WORK WAS STARTED IN 2022 AND THE DOSE RESPONSE ASSAY WAS COMPLETED IN 2023.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Ariel Peters President | Trustee | 1 | $0 |
Geri Landman Director, Secretary, Treasurer | OfficerTrustee | 8 | $0 |
Nicole Soussan Director | Trustee | 1 | $0 |
Jillian Wetzel Director | Trustee | 1 | $0 |
Amanda Griffith Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $143,614 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $143,614 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $143,614 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $66,984 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $75 |
| Office expenses | $98 |
| Information technology | $75 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $364 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,360 |
| All other expenses | $0 |
| Total functional expenses | $70,254 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $328,645 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $328,645 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $328,645 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $328,645 |
Grants Awarded
Over the last fiscal year, Moonshots For Unicorns has awarded $140,952 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
NATIONWIDE CHILDREN'S HOSPITAL RESEARCH INSTITUTE PURPOSE: This grant was made to support research aimed a creating an effective gene therapy to cure the monogenic disorder PGAP3-CDG. | $125,952 |
PERLARA PBC PURPOSE: This grant supported drug repurposing research aimed at curing the monogenic disorder PGAP3-CDG. The money supported creation and characterization of PGAP3 knockout yeast and testing of existing medications on those yeast. | $15,000 |